Edition:
United States

Health News

Photo

Mylan reiterates profit on EpiPen two-pack in U.S. 1:04pm EDT

Under fire generic drugmaker Mylan NV reiterated it makes a net profit of $104, after taxes, for a pair of its EpiPen emergency allergy treatment sold in the United States, the company said in a filing on Monday.

More Headlines

Care home nurses need training for unique role

(Reuters Health) - The most important thing nurses provide to nursing home patients are dignity, personhood and quality of life, but training in these aspects of care is lacking, according to a U.K. study.

12:57pm EDT
Photo

Vela Diagnostics gets emergency U.S. authorization for Zika test

Vela Diagnostics said its test for the Zika virus had received "emergency use authorization" from the U.S. Food and Drug Administration.

8:27am EDT

Investors urge food companies to shift from meat to plants

LONDON A group of 40 investors managing $1.25 trillion in assets have launched a campaign to encourage 16 global food companies to change the way they source protein for their products to help to reduce environmental and health risks.

3:33am EDT

Third win for cannabis drug in epilepsy sends GW to record high

An experimental cannabis-derived drug has successfully treated children with severe epilepsy in a third late-stage clinical trial, sending shares in Britain's GW Pharmaceuticals to a record high on Monday.

9:08am EDT

Health Watch Graphics